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In a brain MRI report, the following words often appear: “clinical clinicians, this would represent a need to submit more information
correlation is recommended”. These words signify that inadequate clin-
ical informationwas provided, or that an unexpectedﬁnding on theMRI
should be assessed clinically. “Clinical correlation is recommended” is
less common in a report about a single gene or simple gene panel.
This is because the very act of ordering the test conveys much of what
is important about the clinical situation, and only rarely is further infor-
mation needed.
Genetics labs are moving into new territory as they adopt next-
generation genomic sequencing. When moving beyond single gene
tests and simple panels, more clinical correlation is needed. The com-
plexity of interpretation becomes similar to a brain MRI, only more so.
In an exome, thousands of variants are found. Even after comparing
to other family members, and using estimates of variant pathogenicity,
many genes must be considered. Sometimes clinical correlation can be
as simple as using the key clinical ﬁnding, assuming that you know
which ﬁnding is key. But sometimes the situation is more complicated:
variants are found in a gene that hadn't been considered clinically, or
two genes are needed to explain the clinical picture, and more clinical
correlation is needed.
For brain MRI scans, this clinical correlation is institutionalized as
neuroradiology rounds held several times a week by many neurology
inpatient services. How should the analogous clinical correlation for
genomic interpretation be structured?
The core principle of clinical correlation should be that detailed
information about the patient's ﬁndings, the phenotype, is combined
with detailed information in the annotated variant table, the genotype.
Since this is done in the wider context of considering all known pheno-
types, the result is a “genome–phenome” analysis.
In what venue should the “aha” of this clinical correlation occur?
Each venue has plusses and minuses:
• External lab: For the external lab to do the clinical correlation, the
referring clinicians need to send phenotypic information to the lab,
with the full detail used in clinical reasoning, including onset ages of
ﬁndings and pertinent negatives (Segal et al., 2014). The lab needs
solid clinical expertise to use this information, and needs to ask for
and receive more clinical information as unanticipated gene abnor-
malities are detected. For most labs, this would represent an increase
in clinical expertise and clinical communication, and for referringE-mail address: appliedtranslationalgenomics2015@simulconsult.com.
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records from which it is difﬁcult or impossible to extract the relevant
ﬁndings, let alone onset information or pertinent negatives.
• Hospital-based: For hospital-based clinicians to do the clinical correla-
tion, the clinicians who know the patient need the expertise to work
with an annotated variant table. The sequencing and annotation
could be done internally, or by an external lab, which can share an an-
notated variant table annotated variant table under CLIA ruleswithout
triggering a “reporting event”. For most clinical geneticists, analyzing
a variant table would represent an increase in expertise, requiring sig-
niﬁcant training. If sequencing were to be done internally rather than
in an external lab, this would represent an increase in genomic exper-
tise needed in the hospital, with a danger of falling behind external
labs that have the scale to use crucial advanced capabilities such as
family-aware variant calling and exome sequencing that includes
enhanced coverage of disease genes (Segal et al., 2015).
• Hybrid: Genome and phenome expertise can be united by having
meetings of clinical and genomic experts similar to neuroradiology
rounds or tumor boards. This hybrid venue involves delays and over-
head of big teams, but unites deep expertise in both genome and
phenome. The efﬁcacy of the process would depend on the quality
and efﬁciency of this communication between clinical and genomic
experts.
Each of these models involves considerable training or overhead
to combine genome and phenome information. However, the ability
to do so is greatly facilitated by software tools that help combine
genomic and clinical expertise. Such software has developed in a step-
wise process and is now in use among clinicians and lab experts:
• Clinical diagnosis became more systematized: Clinicians have become
increasingly open to computerized assistance in clinical diagnosis.
The openness came in part from younger clinicians who cope with
considering thousands of diagnoses the same way that they deal
with other areas of daunting information — by using computerized
tools. This openness has encouraged systematized clinical terminology,
detailed descriptions of ﬁndings in known diseases, and the software
to combine this information (Segal and Leber, 2012).
• Genome–phenome analysis becamemore systematized: Building on clin-
ical diagnostic software, genome–phenome analysis is becoming
systematized in a way that is hypothesis-independent as to thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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clinical ﬁndings are important. Computational metrics such as
“pertinence” can bridge the divide between genome and phenome
information by highlighting genes that inﬂuence the differential diag-
nosis (Segal et al., 2015).
• Communication improves as its power is demonstrated: When clinicians
are part of the process of genome interpretation, they see the impor-
tance of providing robust phenotypic information and helping curate
information about known phenotypes. Seeing the difference between
“garbage in, garbage out” and “quality in, quality out” is worth a thou-
sand exhortations.
As labs go through the cultural shift from single gene tests to geno-
mic analysis, it is crucial to focus on the process of clinical correlation,
the venue in which it is done, and the tools that can help get clinical
and genomic experts “on the same page”.
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